Szot Matthew K sold CVKD
September 29, 2025 · Form 4 insider transaction
Szot Matthew K sold 100 shares of Cadrenal Therapeutics, Inc. at $14.00 per share, a transaction worth $1.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$14.00
Total value
$1.4K
InsiderSzot Matthew K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 29, 2025
Filing dateOctober 1, 2025
Shares owned after18,833
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement.